MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from equity
offerings, net of discounts...
$400,562K
(259.71%↑ Y/Y)
Proceeds from short-term
borrowings
$2,884K
Proceeds from exercise of
oberland stock option,...
$220K
(-69.23%↓ Y/Y)
Net cash provided by
financing activities
$400,241K
(42.12%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$15K
(165.22%↑ Y/Y)
Canceled cashflow
$3,425K
Net change in cash
and cash...
-$54,481K
(55.30%↑ Y/Y)
Canceled cashflow
$400,256K
Change in fair value of
related-party convertible...
-$42,773K
(-198.39%↓ Y/Y)
Non-cash interest
expense related to...
$41,229K
(8.49%↑ Y/Y)
Stock-based compensation
expense
$36,809K
(6.90%↑ Y/Y)
Depreciation and
amortization
$15,525K
(-11.56%↓ Y/Y)
Loss on equity method
investment
$14,018K
Non-cash lease expense
related to operating...
$3,502K
Accrued expenses and
other liabilities
$3,184K
(311.14%↑ Y/Y)
Non-cash lease expense
related to operating...
$2,754K
Prepaid expenses and
other current...
-$2,211K
Transaction costs allocated
to warrant...
$2,167K
Other assets
-$803K
(-172.47%↓ Y/Y)
Loss due to write-off
of fixed assets
$570K
(422.94%↑ Y/Y)
Due to and due from
related parties, net
$477K
(-37.48%↓ Y/Y)
Proceeds from maturities
of marketable debt...
$64,897K
(-43.85%↓ Y/Y)
Proceeds from sales of
marketable debt...
$30,927K
(47.12%↑ Y/Y)
Net share
settlement for rsus vesting
$2,265K
(-58.55%↓ Y/Y)
Principal payments on
premium financing
$1,132K
Principal payments of
finance leases
$28K
(-56.25%↓ Y/Y)
Net cash used in
operating activities
-$304,936K
(22.06%↑ Y/Y)
Canceled cashflow
$166,022K
Net cash used in
investing activities
-$149,801K
(-1123.26%↓ Y/Y)
Canceled cashflow
$95,824K
Net loss
-$351,472K
(15.03%↑ Y/Y)
Change in fair value of
warrant liabilities
-$49,089K
(-146.00%↓ Y/Y)
Accounts receivable
$40,211K
(1603.86%↑ Y/Y)
Prepaid expenses and
other current...
$7,068K
Change in fair value of
derivative liabilities
-$6,398K
(52.53%↑ Y/Y)
Inventories
$6,325K
(-23.54%↓ Y/Y)
Operating lease
liabilities-Nonrelated Party
-$3,749K
Operating lease
liabilities-Related Party
-$3,461K
Non-cash interest items,
net (including...
$2,745K
(84.35%↑ Y/Y)
Non-cash interest items,
net
$250K
(121.74%↑ Y/Y)
Accounts payable
-$190K
(94.00%↑ Y/Y)
Purchases of marketable
debt securities,...
$241,373K
(72.14%↑ Y/Y)
Purchases of property,
plant and equipment
$3,846K
(-44.16%↓ Y/Y)
Software development
costs
$406K
Back
Back
Cash Flow
source: myfinsight.com
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)